ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Faculty Opinions recommendation of Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.737136530.793583132
◽
2021
◽
Author(s):
Ronald Hoffman
Keyword(s):
Combination Therapy
◽
Polycythemia Vera
◽
Phase Ii
◽
Phase Ii Study
◽
Interferon Α2
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1115745.571827
◽
2008
◽
Author(s):
Nikolaus Kroeger
Keyword(s):
Polycythemia Vera
◽
Phase Ii
◽
Essential Thrombocythemia
◽
Phase Ii Study
Download Full-text
Faculty Opinions recommendation of A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF).
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.727086783.793541456
◽
2018
◽
Author(s):
William Vainchenker
◽
Isabelle Plo
Keyword(s):
Polycythemia Vera
◽
Phase Ii
◽
Essential Thrombocythemia
◽
Phase Ii Study
◽
Primary Myelofibrosis
Download Full-text
Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study)
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-016-3109-4
◽
2016
◽
Vol 78
(3)
◽
pp. 585-593
◽
Cited By ~ 3
Author(s):
Takao Takahashi
◽
◽
Yasunori Emi
◽
Eiji Oki
◽
Kazuma Kobayashi
◽
...
Keyword(s):
Colorectal Cancer
◽
Combination Therapy
◽
Phase Ii
◽
Phase Ii Study
◽
Wild Type
◽
Exon 2
◽
Multicenter Phase
◽
Previously Treated
◽
Kras Exon
Download Full-text
A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)
Gastric Cancer
◽
10.1007/s10120-011-0030-8
◽
2011
◽
Vol 14
(3)
◽
pp. 226-233
◽
Cited By ~ 12
Author(s):
Tetsuya Hamaguchi
◽
◽
Kuniaki Shirao
◽
Atsushi Ohtsu
◽
Ichinosuke Hyodo
◽
...
Keyword(s):
Gastric Cancer
◽
Combination Therapy
◽
Advanced Gastric Cancer
◽
Mitomycin C
◽
Clinical Oncology
◽
Phase Ii
◽
Phase Ii Study
◽
Oncology Group
◽
Japan Clinical Oncology Group
Download Full-text
Multicenter Phase II Study of Combination Therapy with Oral S-1 Plus Cisplatin in Elderly Patients with Advanced Gastric Cancer
Annals of Oncology
◽
10.1093/annonc/mdu165.81
◽
2014
◽
Vol 25
◽
pp. ii39
Author(s):
Iwasa Satoru
◽
Hamaguchi Tetsuya
◽
Nagashima Kengo
◽
Goto Masahiro
◽
Okazaki Shunsuke
◽
...
Keyword(s):
Gastric Cancer
◽
Combination Therapy
◽
Elderly Patients
◽
Advanced Gastric Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Multicenter Phase
Download Full-text
A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis
Leukemia
◽
10.1038/leu.2008.91
◽
2008
◽
Vol 22
(5)
◽
pp. 965-970
◽
Cited By ~ 90
Author(s):
A Quintás-Cardama
◽
W Tong
◽
H Kantarjian
◽
D Thomas
◽
F Ravandi
◽
...
Keyword(s):
Polycythemia Vera
◽
Phase Ii
◽
Essential Thrombocythemia
◽
Phase Ii Study
Download Full-text
A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-010-1278-0
◽
2010
◽
Vol 66
(5)
◽
pp. 987-992
◽
Cited By ~ 12
Author(s):
Manabu Shiozawa
◽
Makoto Akaike
◽
Nobuhiro Sugano
◽
Kazuhito Tsuchida
◽
Naoto Yamamoto
◽
...
Keyword(s):
Colorectal Cancer
◽
Combination Therapy
◽
Phase Ii
◽
Advanced Colorectal Cancer
◽
Phase Ii Study
Download Full-text
Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: A prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut)
Gynecologic Oncology
◽
10.1016/j.ygyno.2007.08.008
◽
2007
◽
Vol 107
(3)
◽
pp. 518-525
◽
Cited By ~ 41
Author(s):
A. du Bois
◽
J. Pfisterer
◽
N. Burchardi
◽
S. Loibl
◽
J. Huober
◽
...
Keyword(s):
Combination Therapy
◽
Phase Ii
◽
Liposomal Doxorubicin
◽
Phase Ii Study
◽
Pegylated Liposomal Doxorubicin
◽
Gynecologic Malignancies
◽
Prospective Phase
Download Full-text
Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-003-0604-1
◽
2003
◽
Vol 52
(2)
◽
pp. 125-130
◽
Cited By ~ 8
Author(s):
Tadamichi Denda
◽
Tomonori Ambo
◽
Atsushi Ohtsu
◽
Yasuhide Yamada
◽
Kuniaki Shirao
◽
...
Keyword(s):
Colorectal Cancer
◽
Combination Therapy
◽
Mitomycin C
◽
Phase Ii
◽
Advanced Colorectal Cancer
◽
Phase Ii Study
Download Full-text
A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-13-3445
◽
2014
◽
Vol 20
(23)
◽
pp. 5976-5985
◽
Cited By ~ 62
Author(s):
Ho Yeong Lim
◽
Jeong Heo
◽
Hye Jin Choi
◽
Cheng-Yao Lin
◽
Jung-Hwan Yoon
◽
...
Keyword(s):
Hepatocellular Carcinoma
◽
Combination Therapy
◽
Phase Ii
◽
Phase Ii Study
◽
Mek Inhibitor
◽
Efficacy And Safety
◽
Asian Patients
◽
Unresectable Hepatocellular Carcinoma
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close